期刊文献+

塞替派诱发人支气管上皮恶性转化成瘤细胞的生物学特性 被引量:2

Biological characteristics of tumorigenic human bronchial epithelial cells induced by thiotepa
下载PDF
导出
摘要 目的 为进一步阐明化学致癌剂的作用机制提供实验依据。方法 利用原代细胞培养,细胞免疫化学分析获得并鉴定恶性转化成瘤细胞,以BEAS 2B细胞和BEAS STE细胞为参照,研究恶性转化成瘤细胞的增殖动力学和锚着独立生长能力等表型特征。结果和结论 经原代细胞培养获得可传代的具人类上皮来源的恶性转化成瘤细胞。 AIM To provide the experimental evidences for explaining the mechamism of chemical tumorigenesis. METHODS Three tumorigenic cell lines derived from tumor tissues were established. Using the BEAS-2B and BEAS-STE cells as control, the dynamics of proliferation and anchorage independence growth of the BEAS-TT cells were studied. RESULTS and CONCLUSION The proliferation rate of the three BEAS-TT cells is slower than BEAS-2B and BEAS-STE cells. The anchorage independence growth capacity of BEAS-TT cells is stronger than BEAS-STE.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2005年第2期133-136,共4页 Chinese Journal of Pharmacology and Toxicology
基金 国家自然科学基金资助项目 ( 3 0 2 71 5 5 9)~~
关键词 塞替派 转化 上皮细胞 肿瘤细胞 培养的 thiotepa transformation, epithelial cell tumor cells, cultured
  • 相关文献

参考文献8

二级参考文献12

共引文献7

同被引文献25

  • 1张雨梅,孙侠,殷俊,潘金春.已烯雌酚致新生鼠肺肿瘤模型的建立[J].癌变.畸变.突变,2006,18(6):462-464. 被引量:2
  • 2Cohen SM,Robinson D,MacDonald J.Alternative models for carcinogenicity testing[J].Toxicol Sci,2001,64(1):14-19.
  • 3Enzmann H,latropoulos M,Brunnemann KD.Short-and intermediate-term carcinogenicity testing,-a review part 2:Available experimental models[J].Food Chem Toxicol,1998,36(11):997-1013.
  • 4Knight A,Bailey B,Balcombe J.Animal Carcinogenicity Studies:3.Alternatives to the Bioassay[J].ATLA,2006,34(1):39-48.
  • 5Dragan YP,Rizvi T,Xu YH,et al.An initiation-protnotion assay in rat liver as a potential complement to the 2-year caranogeta?ss bioassay[J].Fundam Appl Toxicol,1991,16(3):525-547.
  • 6Pritchard JB,French JE,Davis BJ,et al.The role of transgenic mouse models in carcinogen identification[J].Environ Health Perspect,2003,111(4):444-454.
  • 7Wells MY,Williams ES.The transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies-implications for REACH[J].Regul Toxicol Pharmacol,2009,53(2):150-155.
  • 8Long GG,Morton D,Peters T,et al.Alternative Mouse Models for Carcinogenicity Assessment:Industry Use and Issues with Pathology Interpretation[J].Toxicol Pathol,2010,38(1):43-50.
  • 9Flammang Ti,Tungeln LS,Kadlubar FF,et al.Neonatal mouse assay for ttmtorigenicity;alternative to the chronic todent bioassay[J].Regul Toxicol Pharmacol,1997,26(2):230-240.
  • 10McClain RM,Keller D,Casciano D,et al.Neonatal mouse model:review of methods and results[J].Toxicol Pathol,2001,29(Suppl):128-137.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部